![]() | ![]() |
Formats:
|
||||||||||||||||||
Copyright © 2008, Cold Spring Harbor Laboratory Press Segmental duplications and evolutionary plasticity at tumor chromosome break-prone regions 1 Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm SE-171 77, Sweden; 2 Institute for Anthropology and Human Genetics, Department of Biology II, Ludwig-Maximilians-University, Planegg-Martinsried DE-82152, Germany 3Corresponding author.E-mail Maria.Kost-Alimova/at/mtc.ki.se; fax 46-8-330498. Received August 11, 2007; Accepted November 29, 2007. This article has been cited by other articles in PMC.Abstract We have previously found that the borders of evolutionarily conserved chromosomal regions often coincide with tumor-associated deletion breakpoints within human 3p12-p22. Moreover, a detailed analysis of a frequently deleted region at 3p21.3 (CER1) showed associations between tumor breaks and gene duplications. We now report on the analysis of 54 chromosome 3 breaks by multipoint FISH (mpFISH) in 10 carcinoma-derived cell lines. The centromeric region was broken in five lines. In lines with highly complex karyotypes, breaks were clustered near known fragile sites, FRA3B, FRA3C, and FRA3D (three lines), and in two other regions: 3p12.3-p13 (~75 Mb position) and 3q21.3-q22.1 (~130 Mb position) (six lines). All locations are shown based on NCBI Build 36.1 human genome sequence. The last two regions participated in three of four chromosome 3 inversions during primate evolution. Regions at 75, 127, and 131 Mb positions carry a large (~250 kb) segmental duplication (tumor break-prone segmental duplication [TBSD]). TBSD homologous sequences were found at 15 sites on different chromosomes. They were located within bands frequently involved in carcinoma-associated breaks. Thirteen of them have been involved in inversions during primate evolution; 10 were reused by breaks during mammalian evolution; 14 showed copy number polymorphism in man. TBSD sites showed an increase in satellite repeats, retrotransposed sequences, and other segmental duplications. We propose that the instability of these sites stems from specific organization of the chromosomal region, associated with location at a boundary between different CG-content isochores and with the presence of TBSDs and “instability elements,” including satellite repeats and retroviral sequences. The evolution of species and the development of cancer are both Darwinian processes based on variation and selection. In our earlier analysis of the human 3p12-p22 segment, we have found a certain concordance between human–mouse synteny breaks, and tumor-associated deletions (Kiss et al. 2002; Kost-Alimova et al. 2003). Later, based on comparative sequence analysis of one tumor-related deletion at 3p21.3 (named CER1), this association has been extended to other features of evolutionary plasticity, including gene duplications, retrotranspositions, and repeated chromosome rearrangements (Darai et al. 2005). Our cancer chromosome studies were focused on the analysis of deletions, detected by the “elimination test,” based on the transfer of human chromosome 3 (chr 3) into mouse fibrosarcoma (A9) cells, and the subsequent identification of eliminated versus retained chr 3 segments after in vivo tumor growth (Imreh et al. 1994; Yang et al. 1999; Kholodnyuk et al. 2002; Kost-Alimova and Imreh 2007). Therefore, the question remained open as to whether the association between tumor and evolutionary breaks observed in a model system could be found in human tumors, and if the answer is affirmative, do these break-prone regions have any structural characteristics? Recently, it was shown that ~5% of the human genome is composed of duplicated genomic segments, which emerged mostly during the past 35 million years of primate evolution. These segmental duplications (SDs) range from a few to hundreds of kilobases and share a high degree of sequence identity (>90%) (Eichler 2001; Samonte and Eichler 2002; Bailey and Eichler 2006). They have gone through extensive structural changes during a relatively short evolutionary time and were associated with chromosomal rearrangements in recent primate evolution (Samonte and Eichler 2002; Courseaux et al. 2003; Nahon 2003; Stankiewicz et al. 2003; Murphy et al. 2005a; Goidts et al. 2006; She et al. 2006). We decided to test whether these regions show signs of instability in human carcinoma cells, as judged by the analysis of tumor related breakpoints. Such analysis was not easy to perform earlier. Studies focused on specific sites like loss of heterozygosity (LOH) or locus-specific FISH were often biased by the choice of markers, guided by earlier studies and by the inevitable concentration on particular regions. Genome-wide studies, like karyotyping, metaphase CGH, multiplex FISH (M-FISH), or spectral karyotyping (SKY) have low resolution. In spite of these drawbacks, the earlier studies suggested a certain correspondence between evolutionary and cancer-related breakpoints. Our study showed a certain concordance between the positions of homozygous deletions at 3p12-p22 in human carcinoma lines and breaks on the mouse–human synteny maps (Kost-Alimova et al. 2003). Another human genomic region, 17p11.2-p12, is rich in SDs and is rearranged both in evolutionary and in cancer-related structural chromosome aberrations (Barbouti et al. 2004; Stankiewicz et al. 2004). Performing multispecies alignments, Murphy et al. (2005b) examined the relationship between the evolutionary and cancer-associated chromosome breakpoints using the Mitelman Database of Chromosome Aberrations in Cancer (http://cgap.nci.nih.gov/Chromosomes/Mitelman). They have found that frequent cancer-associated chromosome aberrations were close to evolutionary breakpoint regions three times as often as were the less frequent cancer-associated aberrations. Our multipoint FISH (mpFISH) method permits the detection of chr 3 rearrangements in tumor cell lines very efficiently (Darai-Ramqvist et al. 2006). We have chosen 10 carcinoma cell lines for the analysis of breakpoints. Chr 3 is one of the most rearranged chromosomes in different human carcinomas (Kost-Alimova and Imreh 2007; Kost-Alimova et al. 2007); renal cell carcinoma, which represents a majority of our cell line samples, is one of them (van den Berg and Buys 1997; Meloni-Ehrig 2002; see also Mitelman Database of Chromosome Aberrations in Cancer). The number of rearrangements varied from three up to 68 per karyotype as detected by M-FISH. Using mpFISH we found up to 20 chr 3 breaks per cell line. We detected a total of 54 different breakpoints on chr 3 in the 10 cell lines. In the lines with high karyotype complexity they clustered at three known fragile sites, FRA3B, FRA3C, and FRA3D, and at two other regions, 3p12.3-p13 and 3q21.3-q22.1. As we show, the characterization of the last two tumor break-prone regions sheds some light on five questions we were most interested in:
Results Tumor break-prone regions in carcinoma cell lines We have previously analyzed several carcinoma cell lines by M-FISH and metaphase CGH. The average number of structural chromosomal changes varied in these cell lines and reflected the complexity of karyotype (Supplements 1 and 2). In this study we analyzed 10 carcinoma lines by painting three chromosomes (2, 3, and 12) and using mpFISH (Supplement 3). We detected 54 chr 3 breakpoints, of which 30 were involved in unbalanced translocations, 14 in interstitial deletions, seven in duplications, one in balanced translocations, and two in insertions (Supplement 4). We differentiated cell lines according to chromosome breakage frequency (Supplement 5). The first group (UOK125, KH39, and UOK115) had, on average, less than one break per chromosome, as shown by painting, and maximum one break per chr 3, as shown by mpFISH. The second group (TK-164, Caki-1, A498, and U2020) had one to three breaks per chromosome, as shown by painting, and two to four breaks per chr 3, as shown by mpFISH. The high karyotype complexity group, including Caki-2, UOK147, and HONE1, had more than three breaks per chromosome, as shown by painting, and 10–20 breaks per chr 3, as shown by mpFISH. Increased resolution (up to 1 Mb by mpFISH) did not improve the detection of rearrangements in low and moderate complexity lines, showing that the low complexity was not due to a lack of resolution. In contrast, the number of detected rearrangements increased with the improvement of the methods in the cell lines with high chromosome complexity Caki-2, UOK147, and HONE1. Totally, 41 breaks on chr 3 were detected in these three lines by mpFISH. These cell lines also had high ploidy: UOK147 and HONE1 were hypotetraploid, Caki-2 was hypopentaploid. The mpFISH resolution was sufficient to conclude that the breakpoints were not identical, but clustered in particular regions spanning few megabases. To establish the criteria for the identification of tumor break-prone areas, we kept in mind that unbalanced rearrangements generated by end joining of fragments might involve a breakpoint distant to the fusion-point; and the break-prone region may span over several megabases, as exemplified by FRA3B (Becker et al. 2002). The probability of having a break-prone region near to a rearrangement breakpoint would be high within the adjacent region lost during a rearrangement and would decline at both ends of the region. The shape and size of single probability profiles were estimated empirically (Supplement 6), so that the superposition of such profiles gave the best break-prone area identification on the cumulative profile (Fig. 1A,B
Tumor break-prone segmental duplication (TBSD) We analyzed the distribution of SDs along chr 3 in relation to their size (Fig. 1C FISH analysis using BAC probes from TBR1 (Fig. 2
The other duplication partners were: chr3:15, chr4:4, chr4:9, chr7:7, chr7:97, chr8:7, chr8:12, chr11:4, chr11:67, chr11:71, chr12:8, and chr16:5 (Supplement 7). In the following, we will refer to these homologous sequences as tumor break-prone segmental duplication (TBSD) based on their involvement in chromosome breakages in carcinoma samples. Involvement of chr 3 TBSDs was shown using our mpFISH results; to analyze involvement of other TBSDs, we used the Mitelman Database of Chromosome Aberrations in Cancer (http://cgap.nci.nih.gov/Chromosomes/Mitelman). We found that pericentromeric and subtelomeric bands participated in carcinoma-associated chromosome rearrangements 2.5 times more often than interstitial bands. The majority of TBSD containing or adjacent bands (in the cases where a TBSD was located at the band boundary) were even more frequently involved (>3 times). The interstitial 3p13, 3q21, 7q22, and 11q13 bands were among the most frequent break-prone sites in carcinomas. The TBSD expanded in Homininae We compared the sequence of TBSD at chr3:75 with the 14 other TBSDs (chr3:15, chr3:127, chr3:131, chr4:4, etc.) using Dot Plot output of the PipMaker program. TBSD consisted of seven parts (Supplement 7), which were differently represented in different chromosomal locations as shown in Figure 3
We have analyzed orangutan and gorilla chromosomes by FISH with three probes. The BAC RP11-266L17 from the region telomeric to chr3:75 TBSD gave unique signals on human, gorilla, and orangutan chromosomes, identifying the human chr 3 orthologs (red in Fig. 4
TBRs are “hot spots” of chromosomal breaks in mammalian evolution We analyzed the conservation of chr 3 segments in other sequenced species. Figure 1E
We were interested how the human-branch-specific synteny breaks, which occurred before the human–rhesus divergence, are distributed around the TBSDs. We, therefore, studied the breaks, which were not associated with TBSD but with the surrounding region, since the TBSD appeared there after human–rhesus divergence. The sequence windows closest to TBSDs contained the highest number of the breaks (Fig. 5D TBSDs are located at the transitions between CG-rich and CG-poor areas We analyzed different sequence characteristics of the 15 regions, corresponding to each TBSD and of three adjacent sequence windows of the same size (Fig. 6
TBSDs and their close surroundings show enrichment in SDs, satellite, long terminal repeats, and retroposed pseudogenes The “SD” chart in Figure 6 Analyzing the chr3:75 TBSD (Supplement 7), we found that it was flanked by satellite repeats SATR1 and SATR2, which contained an LTR repeat, HERVE, which belongs to the ERV1 endogenous retroviruses family. We studied the distribution of SATR1, SATR2, and HERVE along chr 3 (see Fig. 1G Discussion Development of a new, high-resolution modification of FISH (mpFISH) allowed us to perform a thorough chr 3 analysis in 10 carcinoma cell lines and to identify tumor break-prone regions. Two of these regions (bands 3p12-13 and 3q21) were known to be involved in some cancer-associated chr 3 aberrations, but were not described previously as “instability sites.” The rearrangements within these novel “instability sites” designated TBRs were mostly unbalanced translocations. They were particularly frequent in hyperploid tumor lines with multiple chromosomal aberrations. Sixteen breaks within the TBRs and 21 breaks in fragile sites formed almost three-fourths of all breaks in the moderate (two to four chr 3 rearrangements in TK-164, Caki-1, A498, and U2020) and high complexity karyotype cell lines (10 to 20 chr 3 rearrangements in Caki-2, UOK147, and HONE1). Breaks around TBRs were found in all cell lines of these two categories, except one; while fragile sites were only broken in three cell lines, with high-complexity karyotype participating in interstitial deletions and amplifications. In the introduction we formulated five questions concerning tumor break-prone regions. We will attempt to answer these questions based on our results. A TBR “epicentre” is characterized by specific sequence features The chromosomal rearrangements had highest incidence in close proximity to “epicentres” of TBR1 and TBR2. We found one of the largest (~250 kb in size) and evolutionarily youngest (spread after human–orangutan divergence) SDs (designated TBSD) there. These TBSDs were located at the 75, 127, and 131 Mb positions. The majority of the TBR breakpoints (10 of 16) were within 1-Mb areas surrounding the TBSDs; two were inside the SDs. The other six unbalanced translocation fusion points were within 5-Mb areas, surrounding the “epicenter,” and the TBSDs were lost due to these unbalanced translocations. This leaves us with two possible explanations. Breaks may occur within or close to the TBSD, followed by the digestion of free ends and the loss of the TBSD, before joining the other chromosomal fragment end. Alternatively, breaks occur within a large unstable region that surrounds the TBSD with a higher chance in its close surroundings. The TBSD has a complex origin and is found at 15 locations in the human genome. The majority of them lie at the transition between higher and lower CG-content areas and are flanked by satellite (SATR1 and SATR2) and LTR (HERVE) repeats. Using the Mitelman Database of Chromosome Aberrations in Cancer, we found that these locations are also “hot spots” of carcinoma-related chromosomal rearrangements. TBRs correspond to evolutionary break-prone regions Structural instability provides an evolutionary opportunity for the recycling of certain chromosomal regions (Bourque et al. 2004; Zhao et al. 2004; Darai et al. 2005; Murphy et al. 2005b). We checked whether TBRs belong to these “recycling sites.” Human–rhesus sequence comparison identified breaks between homologous segments on chr 3 (see Fig. 1E Organization of TBSDs and their surroundings (see Figs. 3 Our findings confirm and add more evidence to Haaf and colleagues’ hypothesis about evolutionary plasticity of the primate-specific chr 3 breakpoint regions (Tsend-Ayush et al. 2004; Yue et al. 2005, 2006; Yue and Haaf 2006). Possible mechanisms of instability at the TBSDs As we mentioned, the breakpoints detected by us on chr 3 in carcinoma cell lines were clustered around, but not necessarily within the TBSD; the majority of rearrangements were unbalanced translocations leading to loss of the TBSD. This speaks against nonallelic homologous recombination (NAHR), which was suggested as a main mechanism of chromosomal rearrangements that involve SDs (Samonte and Eichler 2002; Stankiewicz and Lupski 2002; Locke et al. 2003; Dennehey et al. 2004; Muller et al. 2004; Shaw and Lupski 2004; Murphy et al. 2005a). NAHR does not explain all evolutionary rearrangements that involve the TBSDs as well (see Fig. 3 TBSDs were inserted into TBRs after human–rhesus divergence. In the majority of cases, they flanked homininae-specific inversions (see black double-headed arrows in Fig. 3 Interestingly, three out of seven primate-specific inversions (see chr3:75-pter; chr7:7-97, and chr11:4-71 in Fig. 7 Isochores are characterized by specific density and replication time (Costantini et al. 2006; Schmegner et al. 2007). Thus, the boundary represents a region of dramatic change in chromatin structure and function. Replication, which starts early in high-CG isochore, pauses for several hours at the transition to low-CG isochore (Schmegner et al. 2007). It was proposed that replication disturbance at the transition between these zones may explain “fragility” of certain regions (Debatisse et al. 2006). The presence of satellite-rich sequences with a potential to form unusual secondary structures may enhance this instability effect, as it was shown for rare and common fragile sites (Zlotorynski et al. 2003; Gericke 2006) and for human rRNA genes (Lebofsky and Bensimon 2005). Palindromic repeat mediated genomic plasticity has been demonstrated to promote a variety of translocations (Tapia-Paez et al. 2000, 2001; Kurahashi and Emanuel 2001; Kurahashi et al. 2003) and even cancer-associated somatic rearrangements (Barbouti et al. 2004). Replication asynchrony and delay also characterize polysomic regions (Kost-Alimova et al. 2004) and gene duplications (Gimelbrant and Chess 2006). Thus, incomplete replication within these regions of special organization may lead to breakage and chromosomal rearrangements under certain conditions. Another instability mechanism within the TBSDs may be related to over-representation of LTR retrotransposons. They predominantly belong to several families of human endogenous retroviruses (HERVs). HERV elements are usually densely methylated in normal somatic cells, but if activated, they may contribute to chromosomal instability in cancer (for review, see Schulz et al. 2006). We found that HERVE elements flanked by SATR repeats at the TBSD boundaries are juxtaposed to the most flexible, frequently duplicated, or deleted parts of the TBSD (see “putative instability element” in Fig. 3 Selective value of the changes within TBSDs Evolutionary and tumor-related instability features of the described break-prone regions, which include breakage and accumulation of SDs, suggests that these regions can be “recycled” in different species and in cancer cells. What is the selective value of these changes? We found that at least one group of functional genes was involved in the “recycling.” The FAM86 family has expanded together with the TBSDs in higher primates. The genes of this family are active in the human genome, as shown by mRNA alignments, but their function is not known. It may be noted that they contain the S-adenosyl-L-methionine-dependent methyltransferase superfamily domain. Methyl transfer from the ubiquitous donor S-adenosyl-L-methionine to nitrogen, oxygen, or carbon atoms occurs frequently in many organisms ranging from bacteria to plants and mammals. The reaction is catalyzed by methyltransferases and modifies DNA, RNA, proteins, and small molecules such as catechol, which participate in gene regulation and differentiation. The selective growth advantage of the rearrangements in TBSD regions may not be dependent entirely on their gene content. Breakage in tumors often leads to the loss of large chromosomal fragments. Changes in gene expression that occur in the wake of such losses may convey growth advantage. Alternatively, it can change the copy number of specific genes. For example, the rearrangements within chr3:75 resulted in 3p12-pter losses in the majority of cell lines analyzed by us. The loss of distal 3p genes may be advantageous due to the well-documented presence of multiple tumor suppressor genes on 3p (Zabarovsky et al. 2002; Imreh et al. 2003). Conclusion Identification and analysis of chr 3 regions 3p12-p13 and 3q21.3-q22.1, involved in tumor-related breaks, showed that they have also played an important role both in the recent evolution of primates and generally in mammalian evolution. The main feature common to both regions was the presence of specific SDs, designated tumor break-prone segmental duplications (TBSDs). The chromosomal regions containing TBSD share common sequence features related to the regional instability:
Methods Cell lines Ten carcinoma-derived cell lines were analyzed. Eight were derived from renal-cell carcinoma: KH39, A498, UOK115, UOK125, UOK147, TK-164 (Bear et al. 1987; Gnarra et al. 1994; Tomita et al. 1996), Caki-1 (ATCC catalog no. HTB46), and Caki-2 (ATCC catalog no. HTB47). U2020 was derived from small cell lung cancer (Heppell-Parton et al. 1999). HONE1 was a human nasopharyngeal carcinoma cell line (Glaser et al. 1989). All cell lines were cultured on IMDM medium with 10% fetal calf serum, 1% penicillin-streptomycin, and 1% glutamine. For fluorescence in situ hybridization (FISH) experiments, cells were treated with 0.1 μg/mL colcemid for 3–4 h to obtain metaphase chromosomes. After treatment with hypotonic solution, cells were fixed in methanol:acetic acid (3:1). FISH FISH was performed on metaphase spreads prepared from the described cell lines using chr 3-, chr 2-, and chr 12-specific painting probes labeled with FITC, Cy3, and biotin, respectively (Cambio). The biotin-labeled probe hybridization was detected with Cy5 conjugated streptavidin (Amersham Biosciences, GE Healthcare Worldwide). A total of 179 BAC/PAC clones, which covered the chr 3 with a resolution of ~1 Mb, were used for comparative analysis of carcinoma cell lines by mpFISH and arrayCGH in our earlier study (Darai-Ramqvist et al. 2006). Metaphase mpFISH data from 176 clones, which were proven to be on chr 3, were used in the present study to analyze distribution of breakpoints on chr 3 in 10 cell lines. To map the breakpoints within TBSDs and to analyze TBR1 in human, gorilla, and orangutan chromosomes, we used 11 clones that were inside and close to TBSDs (BACPAC Resources Center, Children's Hospital Oakland, CA). BAC/PAC DNA was isolated using QIAGEN columns (QIAGEN, Inc.) and labeled with nick-translation either with biotin-dUTP or digoxigenin-dUTP (BIO-Nick Translation Mix or Digoxigenin-Nick Translation Mix, Roche Molecular Biochemicals). FISH and analysis were performed as described (Darai-Ramqvist et al. 2006). Biotin-labeled probes were detected with Cy3-conjugated streptavidin (Amersham Biosciences, GE Healthcare Worldwide) and digoxigenin-labeled probes with FITC-conjugated anti-digoxigenin antibodies (Roche Molecular Biochemicals Mannheim). Metaphase plates were analyzed for each painting and mpFISH probe using a fluorescence microscope (Leitz-DMRB, Leica) equipped with a Hamamatsu C 4800 cooled CCD camera (Hamamatsu) and Adobe Photoshop 7.0 (Adobe Systems). Database analysis UCSC Genome Bioinformatics Site (http://genome.ucsc.edu) was used for majority of searches. The March 2006 human reference sequence (NCBI Build 36.1), as well as other specie latest-reference sequences were analyzed using the tracks listed below in the UCSC Genome Browser (Kent et al. 2002). The May 2004 human assembly was used for analysis of retroposed sequences, including pseudogenes and some bacterial artificial chromosome (BAC) end sequences, which were missing from the March 2006 assembly. The results obtained in the May 2004 assembly were converted to positions corresponding to the March 2006 assembly. BAC End Pairs Track and FISH Clones Track, helped us to identify positions of mpFISH probes and to order FISH probes for TBR1 analysis. To identify segmental duplications, Segmental Duplications Track, was analyzed. Repeat contents were determined using Repeating Elements by RepeatMasker Track. Conservation of chromosome segments in other sequenced species was identified using Net Traks. To obtain information about approximate location of bands seen on Giemsa-stained chromosomes, Chromosome Band Track was used. GC Percent Track was used to analyze the percentage of G (guanine) and C (cytosine) bases. Known Genes Track identified known protein-coding genes. The mRNA track showed alignments between human mRNAs in GenBank and the genome, produced using the BLAT program. The Superfamily track shows proteins having homologs with known structures or functions. For the analysis of carcinoma-related breakpoint distribution along the human chromosomes, we used the Mitelman Database of Chromosome Aberrations in Cancer (http://cgap.nci.nih.gov/Chromosomes/Mitelman). The Dot Plot output of PipMaker (http://pipmaker.bx.psu.edu/pipmaker) (Schwartz et al. 2000) program was used to identify and illustrate similar parts in two sequences of >100 bp with at least 70% nucleotide identity. Acknowledgments This work was supported by grants from the Swedish Cancer Society, the Swedish Medical Research Council, the Cancer Society in Stockholm, the Cancer Research Institute/Concern Foundation NY-LA, USA, the Karolinska Hospital, and the Karolinska Institute. Footnotes [Supplemental material is available online at www.genome.org.] Article published online before print. Article and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.7010208 References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||
Mamm Genome. 2002 Nov; 13(11):646-55.
[Mamm Genome. 2002]Proc Natl Acad Sci U S A. 2003 May 27; 100(11):6622-7.
[Proc Natl Acad Sci U S A. 2003]Genomics. 2005 Jul; 86(1):1-12.
[Genomics. 2005]Genomics. 1999 Dec 1; 62(2):147-55.
[Genomics. 1999]Genes Chromosomes Cancer. 2002 Jul; 34(3):341-4.
[Genes Chromosomes Cancer. 2002]Trends Genet. 2001 Nov; 17(11):661-9.
[Trends Genet. 2001]Nat Rev Genet. 2002 Jan; 3(1):65-72.
[Nat Rev Genet. 2002]Nat Rev Genet. 2006 Jul; 7(7):552-64.
[Nat Rev Genet. 2006]Genome Res. 2003 Mar; 13(3):369-81.
[Genome Res. 2003]Genetica. 2003 Jul; 118(2-3):193-208.
[Genetica. 2003]BMC Genomics. 2006 Dec 29; 7():330.
[BMC Genomics. 2006]Semin Cancer Biol. 2007 Feb; 17(1):19-30.
[Semin Cancer Biol. 2007]Genes Chromosomes Cancer. 1997 Jun; 19(2):59-76.
[Genes Chromosomes Cancer. 1997]Am J Med Genet. 2002 Oct 30; 115(3):164-72.
[Am J Med Genet. 2002]Oncogene. 2002 Dec 12; 21(57):8713-22.
[Oncogene. 2002]Cancer Lett. 2006 Jan 28; 232(1):13-26.
[Cancer Lett. 2006]Gene. 2002 Aug 21; 296(1-2):21-7.
[Gene. 2002]Genomics. 2006 Nov; 88(5):564-71.
[Genomics. 2006]Genomics. 2005 Jan; 85(1):36-47.
[Genomics. 2005]Genomics. 2005 Jan; 85(1):36-47.
[Genomics. 2005]Gene. 2002 Aug 21; 296(1-2):21-7.
[Gene. 2002]Science. 2007 Apr 13; 316(5822):243-6.
[Science. 2007]Proc Natl Acad Sci U S A. 2000 Jan 4; 97(1):206-11.
[Proc Natl Acad Sci U S A. 2000]Genome Res. 2004 Sep; 14(9):1696-703.
[Genome Res. 2004]Genome Res. 2006 Apr; 16(4):536-41.
[Genome Res. 2006]Genome Res. 2004 Apr; 14(4):507-16.
[Genome Res. 2004]Genome Res. 2004 Oct; 14(10A):1851-60.
[Genome Res. 2004]Genomics. 2005 Jul; 86(1):1-12.
[Genomics. 2005]Nature. 2006 Nov 23; 444(7118):444-54.
[Nature. 2006]Genomics. 2004 Feb; 83(2):193-202.
[Genomics. 2004]Genomics. 2005 Jan; 85(1):36-47.
[Genomics. 2005]Cytogenet Genome Res. 2006; 112(1-2):6-10.
[Cytogenet Genome Res. 2006]Nat Rev Genet. 2002 Jan; 3(1):65-72.
[Nat Rev Genet. 2002]Trends Genet. 2002 Feb; 18(2):74-82.
[Trends Genet. 2002]Genome Biol. 2003; 4(8):R50.
[Genome Biol. 2003]Genomics. 2004 Mar; 83(3):493-501.
[Genomics. 2004]Genomics. 2004 Sep; 84(3):458-67.
[Genomics. 2004]Nat Rev Genet. 2006 Jul; 7(7):552-64.
[Nat Rev Genet. 2006]Genome Res. 2006 Apr; 16(4):536-41.
[Genome Res. 2006]Genome Res. 2006 Apr; 16(4):536-41.
[Genome Res. 2006]Cytogenet Genome Res. 2007; 116(3):167-72.
[Cytogenet Genome Res. 2007]Cell Cycle. 2006 Mar; 5(6):578-81.
[Cell Cycle. 2006]Mol Cell Biol. 2003 Oct; 23(20):7143-51.
[Mol Cell Biol. 2003]Med Hypotheses. 2006; 66(2):276-85.
[Med Hypotheses. 2006]Curr Top Microbiol Immunol. 2006; 310():211-50.
[Curr Top Microbiol Immunol. 2006]Am J Hum Genet. 2003 Oct; 73(4):823-34.
[Am J Hum Genet. 2003]Oncogene. 2002 Oct 7; 21(45):6915-35.
[Oncogene. 2002]Genes Chromosomes Cancer. 2003 Dec; 38(4):307-21.
[Genes Chromosomes Cancer. 2003]Cancer Res. 1987 Jul 15; 47(14):3856-62.
[Cancer Res. 1987]Nat Genet. 1994 May; 7(1):85-90.
[Nat Genet. 1994]Int J Cancer. 1996 May 3; 66(3):322-5.
[Int J Cancer. 1996]Cancer Genet Cytogenet. 1999 Jan 15; 108(2):110-9.
[Cancer Genet Cytogenet. 1999]Proc Natl Acad Sci U S A. 1989 Dec; 86(23):9524-8.
[Proc Natl Acad Sci U S A. 1989]BMC Genomics. 2006 Dec 29; 7():330.
[BMC Genomics. 2006]Genome Res. 2002 Jun; 12(6):996-1006.
[Genome Res. 2002]Genome Res. 2000 Apr; 10(4):577-86.
[Genome Res. 2000]